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During  the past three years experimental  studies to determine  the role  of 
the  immune  state  of the  host  (the  mouse)  in  the  development  of antigenic 
variants of influenza  virus type A have been made. At the present time, seven 
successive generations of antigenic variants of influenza  A PR8-S virus, each 
derived from the previous one by serial  passage in the lungs  of mice immu- 
nized with the homologous agent,  have been produced. These variants  show 
no change when passed in non-immune  animals.  The details of the methods 
employed, the serological  and  immunological  characteristics  of the first four 
variants compared with the parent PR8-S strain  have been published  (1,  2). 
As previously reported  the  first four variants  showed a  progressive sero- 
logical  deviation from the parent PR8-S virus. However, while showing  pro- 
gressively less ability to react with antisera of the preceding variants and the 
PR8-S virus they retained the capacity to provoke antibody to the preceding 
variants  and  the parent virus  (2).  The  three most recently derived variants 
show essentially no  reaction  with  PR8 antiserum  while  continuing  to  elicit 
considerable  amounts  of antibody  which  react  with  the  preceding  variants 
and  the original  PR8-S virus.  This  report gives  (a)  the  serological  relation- 
ships  of the  seven variants  to  one another  and  to  the  original  parent  PR8 
virus  and  (b)  the  results  of  cross-hemagglutinin  inhibition  tests  with  the 
certain  epidemic A and A' strains  and  the variant viruses. 
Materials and Methods 
Production  of Variant  Viruses.--The first four and the sixth variants were passed serially 
without  difficulty in  the lungs of mice vaccinated with  the  homologous virus.  During  the 
development of the fifth variant it was necessary to pass the virus alternately in immunized 
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and non-immunized animals to maintain the strain. In the development of aU variants, how- 
ever, it was necessary to begin the homologous passage of the virus in animals with low H.I. 
antibody fiters of 40 to 80. The mice were immunized by the intraperitoneal inoculation of 
0.S  ml.  of formalin-inactivated allantoic fluid influenza virus vaccine. They were then bled 
from the tail vein 9 to 12 days later for determination of individual antibody titers.: For the 
first few passages three mice were selected which had H.I. titers of 40 to 80. They as well as a 
group of six unvaccinated mice were then inoculated intranasally with a  10 per cent mouse 
lung suspension of bonaologous virus. At 48 hours the three vaccinated mice and three mice 
from the unvaccinated group were sacrificed and the lungs from each group pooled. 
The EIDs0 titers of both normal and vaccinated mouse lung virus suspensions were  de- 
termined. If the  EID~0 fiter of the lung virus suspensions from vaccinated mice was 10  -s.° or 
above, it was employed for the subsequent passage. If the EIDs0 virus titer was below 10  -6.0, 
the inng virus suspension from the unvaccinated mice was used to inoculate the next group of 
vaccinated mice. Once the virus grew in high titer in the lungs of immunized  mice with  a 
given antibody titer, animals with higher antibody levels were then employed for subsequent 
passages.To achieve such antibody titers mice were given two or three intraperitoneal doses of 
vaccine at weekly intervals. Final passages were carried out in animals with homologous anti- 
body titers of 1:240 to 1:960 depending upon the variant strain under study. 
When virus was found to grow in high titer in the lungs of mice with high homologous anti- 
body titer it was tested for antigenic variation. H.I.  tests employing  the original and  final 
passage strains as antigens were set up with ferret antisera prepared with the original strain. 
If the H.I.  titer against the final passage strain was significantly (fourfold or greater) lower 
than that observed with the original homologous virus, a new antigenic variant was considered 
to have been produced. After five or more serial passages in the lungs of normal mice a stock 
lung virus suspension was prepared and frozen for subsequent tests. 
Antiserum for each variant was prepared by inoculating two ferrets intranasally with the 
stock lung virus suspension. The animals were bled twice at 14 and 28 days. The antisera were 
then pooled and frozen in small aiiquots. 
Mo~se L~ng Suspensions.--All  mouse lung virus suspensions were prepared by grinding 
the lungs in a sterile mortar with alundum and beef heart infusion broth containing 1000 units 
of penicillin and 1 nag. of dihydrostreptomycin per ml. The supernatant fluid was removed by 
centrifuging the suspension at 1500 g.p.~, for 8 minutes and divided into small aiiquots and 
frozen at  -  40°C. 
Virus for S~rological Tests and Va¢ci.¢s.--In  all serological tests and for all vaccines, in- 
fected allantoic fluids from the first egg passage were used. Ten to eleven day old chick em- 
hryos were inoculated intraallantoically with 0.2 ml. of 10  -4 dilution of mouse lung virus sus- 
pension in antibiotic broth. After 48 hours incubation at 37°C. and chilling overnight at 4°C., 
the ailantoic fluid was harvested, pooled, centrifuged lightly, and dialyzed overnight at 4°C. 
against  10 volumes of 0.85  per cent NaC1 containing 0.01  xt phosphate buffer at  pH  7.0. 
Small aliquots of dialyzed fluid were quickly frozen and stored at  -40°C. in an electric deep 
freeze. 
Preparatio,  of gacci~s.--Formalin to give a  final concentration of 1:4000 was added to 
dialyzed allantoic fluid which was then incubated at 37°C. for 2 hours and kept at 4°C. for at 
least 2 days before use. Vaccine was not kept longer than 1 month at 4°C. 
Serological Tests.--Hemagglutination  (HA) and hemagglutinin-inhibition (H.I.) tests were 
carried out by the method recommended for influenza studies by the Committee on Standard 
Serological Procedures (3). In this test 0.2 ml. each of virus and serum and 0.4 ml. of 0.5 per 
cent washed chicken red blood cells were employed instead of 0.25 and 0.5 ml. respectively. 
Chicken blood ceils were kept at 4 ° in modified Alsever's solution no longer than 7 days. Far 
each day's tests the cells were washed at least three times in 0.85 per cent buffered saline. 
Blood for serum antibody titers in vaccinated mice was obtained by snipping off the tip of DOROTHY  HAMRE,  CLAYTON O.  LOOSLI,  AND  PAUL  GERBER  831 
the tail after heating with an infrared lamp to dilate the vein. The blood was then collected in a 
white blood cell counting pipette previously rinsed in heparin solution (2 rag. per ml.) and 
dried. Blood was drawn to the 1.0 mark and diluted with buffered saline to the 11 mark above 
the bulb. After mixing well, the diluted blood was centrifuged in a  small test tube at 2000 
R.P.M. for 15 minutes and the supernatant fluid withdrawn. Since the dilution of blood in the 
pipette is 1:10 and the average hematocrit value of mouse blood is about 50, the supematant 
fluid was considered to represent a  1:20 dilution of plasma. Therefore, the lowest antibody 
titer that could be determined with the H.I.  test was  1:40. All titers are expressed as the 
reciprocal of the initial dilution of serum giving about 50 per cent H.I. with 4 HA units of 
virus. 
Although the viruses used in this study were not inhibited by normal ferret serum all ferret 
antisera were treated with receptor-destroying enzyme, RDE  (4). 
Neutralization tests were carried out in eggs by the method of HiUeman and Horsfall (5). 
The antibody titers are expressed as the reciprocal of the initial dilution of serum protecting 
50 per cent of the eggs, when approximately 1000 EID~0 of virus are used. 
Because the homologous titers of the antisera used in these tests varied considerably, titer 
that is heterologous titer 
ratios,  homologous titer  X  (100),  were computed in order to facilitate comparison of 
serological results (6). 
Antibody Absorption Tests.--A modification of the method described by Walker and Hors- 
fall (7) was used. Ferret antiserum was diluted so that the H.I. titer was about 64 per 0.2 ml. 
Two ml. of this diluted serum was used to resuspend a pellet of virus spun down from 2 ml. of 
concentrated virus having an HA titer of 4096 to 8192 per ml. After overnight incubation at 
4°C., the mixture was centrifuged at 49,000 g for 45 minutes in a model L Spinco. The super- 
natant fluid was again used to resuspend another pellet of the same virus after which it was 
allowed to stand overnight at 4°C. After centrifuging at 4%000 g in the Spinco, excess virus 
was removed from the supernatant fluid by the addition of 0.1 ml. packed washed chicken red 
blood cells (CRC). After 90 minutes at 4°C. and centrifugation at 2000 z.P.~, for 10 minutes 
to remove the CRC, the supematant serum was tested for residual virus. It was found that the 
treatment with chicken red cells always removed all residual virus. Antibody titers were then 
determined by the H.I. test. 
Virus Titrutions in Eggs.--Determination of EIDs0 virus titration in eggs was carried out 
by intraallantoic inoculation of 0.1 ml. of falling tenfold dilutions into each of four 10 to 11 
day old chick embryos. After 48 hours' incubation at 37°C. and chilling overnight, individual 
allantoic fluids were tested for hemagglutination on a  spot plate (8). The highest dilution of 
virus infecting 50 per cent of the eggs was calculated by the method of Reid and Muench (9). 
Limigng Dil~ions in gggs.--Twofold dilutions of mouse lung virus suspension were made 
beyond the EID60 titer and 0.1 mi. of each dilution inoculated intraallantoically into each of 
fifteen 10 to 11 day old embryonated eggs. After incubating for 96 hours at 37°C. and chilling 
overnight at 4°C., the individual allantoic fluids were tested for hemagglutination on a  spot 
plate. Positive allantoic fluids from dilutions infecting 25 per cent or less of the eggs were 
identified by H.L tests with ferret antisera. To detect inhomogeneity in the mouse lung sus- 
pensions of the viruses, homologous ferret antiserum diluted 1: 5, 1:10, and 1:20 was mixed in 
equal volume with mouse lung virus suspensions diluted 1: 50. After 30 minutes at room tem- 
perature, 0.2 nil. of each serum virus mixture was inoculated intraallantoically into each of 
fifteen eggs which were incubated and tested as described above. 
RESULTS 
The  system used  to designate  the derived  antigenic variants  of influenza A 
PR8  virus is presented  in Table  I.  The  serological  characteristics  of  the first 832  ANTIGENIC  VARIANTS  OF INFLUENZA  A  VIRUS.  III 
four variants,  As, Ba,  Cb,  and Dc have been described  (1,  2).  Continuation 
of the series  led  to the production of three  additional  variants,  Fd,  Gf,  and 
Hg.  The  fifth  variant,  Fd,  was  readily  distinguishable  from its  predecessor 
Dc  after  19  passages  in  mice  immunized  with  Dc.  The  sixth  variant,  Gf, 
was difficult to produce and was maintained  in vaccinated mice only by re- 
sorting  to frequent  passages  in  the  lungs  of normal mice.  After 33  passages 
there appeared  to be only a  slight difference between  Gf and its predecessor 
Fd. Therefore, the passages were halted with no assurance that a new variant 
actually had been obtained. Since it appeared likely that the  Gf variant rep- 
resented  the  end  of  the  possible  antigenic  variations  in  this  series  by  the 
methods employed, its passage in the lungs of mice given homologous vaccine 
was undertaken to confirm this expectation. However, without great difficulty 
TABLE I 
Derivation of Antigenic Variants  of Influenza A  Virus (PR8-S) 
Virus inoculated  Virus used for  No. of passages in  Variant isolated 
intranasally*  immunization of mice  immunized mice 
PR8-S 
As 
Ba 
Cb 
Dc 
Fd 
Gf 
PR8-S 
As 
Ba 
Cb 
Dc 
Fd 
Gf 
22 
25 
17 
26 
19 
33 
33 
As 
Ba 
Cb 
Dc 
Fd 
Gf 
Hg 
* The letter E has been omitted because of its use to denote egg passage. 
another antigenic variant,  Hg, emerged, and it appeared  to be distinct from 
Gf and Fd variants. 
After as many as  20 passages  in lungs of normal mice, no change in sero- 
logical characteristics of the seven antigenic variants could be demonstrated. 
Clones  of  each  of  the  variants  isolated  by  the  limiting  dilution  procedure 
appeared identical with  the virus in the first egg passage used as routine for 
serological tests.  No inhomogeneity could be detected by inoculation of eggs 
with virus mixed with homologous antiserum.  However, it is recognized that 
this  technique  is not sufficiently sensitive  to rule out the presence of a  very 
small proportion of another strain. 
Serological Characteristics of the Variant  Viruses.--The results of cross-H.I, tests are pre- 
sented in Table II. The antibody titers of PR8-S antiserum with homologous  virus and the 
seven variant viruses show a progressive decrease which reaches a titer ratio of < 1 with Fd, 
Gf, and Hg variants. On the other hand, the antibody spectrum of the first four variant viruses 
show little reduction in the proportion of antibody reacting with PR8-S virus compared to 
homologous antibody, e.g. titer ratios decline from 100 with As antiserum, to 50 with De anti- DOROTHY  HAM-RE, CLAYTON  G. LOOSLI, AND  PAUL  GERBER  833 
serum against PR8-S virus. Also, the antisera of As, Ba, and Dc cross-reacted with the virus 
preceding them in the sequence, but only slightly with viruses succeeding them. 
Antiserum of the third variant,  Cb, did not exhibit this phenomenon, but showed high 
titers with the fifth and the sixth variants, Fd and Gf, respectively. Examination of the anti- 
body spectrum of Fd antiserum reveals less cross-reaction with PR8-S and the first two vari- 
ants (As,  Ba) than had been found in antisera to the four preceding variants. However, Fd 
antiserum reacted in high titer with Cb virus as did the Fd virus with Cb antiserum. It ap- 
TABLE II 
Cross-Hemagglutinin-Inhibition Tests with the Parent (PR8-S) 
Influenza Virus and the Seven Variant Strains 
Test viruses  PRS-S  As  Ba  Cb  Dc  Fd  Gf  Hg 
Ferret antisera* 
PR8-S 
As22 
Ba25 
Cbl7 
Dc26 
Fdl9 
Gf33 
Hg33 
1536 
256 
48 
32 
48 
<8 
<8 
8 
768 
768 
192 
24 
128 
<8 
8 
16 
768 
768 
1024 
384 
768 
128 
128 
128 
384 
192 
256 
768 
192 
512 
384 
128 
384 
256 
384 
96 
768 
32 
96 
128 
96  128 
96  64 
96  128 
3~6  384 
96 
768  512 
768  512 
64  96 
256 
192 
192 
384 
192 
128 
192 
512 
Titer ratios~ 
PR8-S 
As22 
Ba25 
Cbl7 
Dc26 
Fdl9 
Gf33 
Hg33 
100 
17 
3 
2 
3 
<1 
<1 
<1 
100 
100 
25 
3 
17 
<1 
1 
2 
75 
75 
100 
37 
75 
12 
12 
12 
* Reciprocal of initial dilution of serum 
Heterologous titer 
X  100. 
Homologous titer 
50 
25 
33 
100 
25 
67 
50 
17 
50 
33 
50 
12 
100 
4 
12 
17 
12  25 
12  12 
12  25 
50  75 
12  19 
100  I00 
100  100 
8  19 
50 
37 
37 
75 
37 
25 
37 
100 
partially (4-) inhibiting 4 HA units of virus. 
peared,  therefore, that these two variants might be similar. Fd antiserum also cross-reacted 
with Gf virus, and indeed the titer ratios obtained with Gf antiserum and all test viruses 
closely resembled those obtained with Fd antiserum. On the basis of H.I. tests seen in Table II 
it might be concluded that no change from the Fd to the Gf variant occurred during passage 
in mice immunized with homologous vaccine. In contrast to the close relationship between 
Gf and Fd, the Hg variant derived from Gf could be distinguished easily from the preceding 
variants, since it reacted only slightly with all antisera as shown by titer ratios ranging from 
< 1 with PR8 antiserum to 19 with Gf antiserum. Moreover, this variant produced antibody 
with a  rather broad spectrum, e.g. titer ratios of Hg antiserum with PR8-S and Cb were 67 
and 75, respectively, and 25 to 37 with the other variants. 
The results of cross-neutralization tests with PR8-S and the seven variant viruses are pre- 834  ANTIGENIC  VARIANTS  OF  IN~LU'ENZA  A  VIRUS. III 
sented in Table III. In general these tests confirmed the results obtained by the H.I. procedure. 
There was a  decline in reaction between PRS-S antibody and the variant viruses, but the 
antisera of the variant strains reacted with PR8-S virus in varying degrees. Only Fd and Gf 
antisera showed significantly lower taters with PRS-S than with the respective homologous 
viruses. Certain cross-reactions among the seven variants were more prominent in the neutral- 
ization test than in the H.I.  test.  For example, antibody titers of Ba antiserum were lower 
TABLE III 
Cross-Neutralization Tests with the Parent (PR8-S)  Influenza  Virus 
and the Seven Variant Strains 
i 
Test viruses  PRS-S  As  Ba  Cb  [  Dc  Fd  Gf  Hg 
Ferret antisera* 
PR8-S 
As22 
Ba25 
Cbl7 
Dc26 
Fdl9 
Gf33 
Hg33 
2900 
91 
20 
12 
22 
6 
4 
8 
280 
316 
20 
<8 
40 
5 
6 
8 
1580 
720 
430 
50 
25 
81 
256 
160 
200 
645 
182 
363 
256 
128 
316 
280 
182 
22 
400 
16 
20 
50 
40 
280 
182 
50 
32 
32 
20 
64 
25 
100 
1118 
32 
81 
40 
20 
45 
25 
40 
25 
91 
Titer ratios~ 
PR8-S 
As22 
Ba25 
Cbl7 
Dc26 
Fdl9 
Gf33 
Hg33 
100 
3 
0.6 
0.4 
0.7 
0.2 
0.1 
0.3 
88 
100 
6 
<2 
12 
2 
2 
2 
89 
40 
100 
3 
24 
3 
1 
4 
40 
25 
31 
100 
28 
56 
40 
20 
79 
70 
45 
5 
100 
4 
5 
12 
14 
9 
14 
71 
3 
18 
25 
25 
15 
50 
19 
78 
100 
25 
89 
43 
22 
49 
27 
43 
27 
100 
* Reciprocal of initial serum dilution preventing infection of half of the eggs when mixed 
with 1000 EIDs0 of virus. 
Heterologous titer 
X  100. 
Homologous fiter 
with Cb virus than with Dc virus, and similarly titers of Dc antiserum were lower with Cb 
than with Ba. This indication of cross-relationship between Ba and Dc was confirmed by 
antibody absorption tests to be discussed below. The possible cross-relationship between Cb 
and Fd variants already shown by cross-H.I,  tests was also present in cross-neutralization 
tests. On the other hand, although Fd and Gf gave similar titer ratios with PR8-S antisera 
and antisera of the other variants, certain differences appeared in the antibody spectrum of 
GI compared with Fd. The titers of Gf antiserum with As and Dc variants were higher than 
those of Fd antiserum with these variants, and the reciprocal cross-reactions between Fd and 
Gf did not have a titer ratio of 100 as they did in the cross-H.I, test. Neutralization tests with 
Hg and its antiserum showed a broad reactivity just as had been shown by cross-H.I, tests. As 
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Of particular interest is the increase in titer ratio to PR8-S virus shown by Hg antiserum com- 
pared with the ratios of the two preceding variants. 
To clarify the extent of antigenic similarities among the variant viruses, antibody absorp- 
tion tests were carried out. 
Absorption of Antibody.--In previous tests (2) absorption of antisera of PR8-S, As, Ba, Cb, 
and Dc with PR8-S  virus removed all antibody from  PR8-S  antiserum, and all antibody 
reacting with PR8-S in the four variant antisera, leaving antibody for the homologous viruses. 
Bd 
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FIO. 2. Cross-absorption tests with Ba and Dc variant viruses and their antisera; and with 
Cb and Fd viruses and their antisera. 
By extending the testing to include five variant viruses including the homologous virus, and 
PR8-S for each antiserum before and after absorption with PR8-S, homologous virus, and the 
preceding and succeeding variant viruses, some of the antigenic components in these viruses 
could be described. It should be pointed out that the designation of a  certain component as 
"new" is not meant in its literal sense. Since all antisera were diluted to have the same H.I. 
titer, about 64, before absorption, minor antibodies might have been diluted out. Therefore, 
as used in this discussion, a new antigenic component refers to one that has not been prominent 
in previous strains in this study. 
The bar graphs in Fig. 1 present the results of absorption of antisera of the first five variants. 
In all absorption tests, homologous virus removed all antibody and is not shown in the figure. 
In the left column of Fig. 1 is shown the remaining antibody of the five variant viruses in each DOROTHY HAMRE, CLAYTON G. LOOSLI~ AND  PAU'LOERBER  837 
serum  after absorption with PR8-S  virus.  Thus,  As antiserum contained antibody which 
reacted only with As virus. Ba antiserum showed titers with both Ba and Dc viruses. Cb anti- 
serum reacted with Ba,  Cb, Dc, and Fd virus but highest with Cb and Fd. Dc antiserum 
showed about the same titer to Ba, Cb, and Dc along with a low titer to As and none to Fd. 
The titers of Fd antiserum with Cb and Fd viruses remained the same as before absorption 
with PR8-S, while the titer to Ba was somewhat lower, and all antibody to As and Dc variants 
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F~¢. 3. Antibody absorption tests with Fd and Gf antisera absorbed with PR8-S, Gf and 
Fd viruses. 
was removed. These results suggest that Ba and Dc share a major antigenic component, and 
similarly Cb and Fd have a common major antigen. 
Cross-absorption between As and Ba variants showed that Ba virus failed to remove all 
antibody in the As antiserum, leaving titers to PR8-S and As, while As virus removed all anti- 
body from Ba antiserum. This could be interpreted as loss of an antigen by Ba virus without 
the addition of a new component. On the other hand, cross-absorptions between Ba and Cb 
variants pointed out the differences between these viruses. Cb virus removed from Ba anti- 
serum only the antibody to itself and the absorption of Cb antiserum with Ba virus gave just 
the opposite reaction, since Ba virus removed titers to PR8-S, As, Ba, and Dc, and left titers 
to Cb and Fd. 
The cross-absorption  of Cb and Dc variants gave results very similar to those just described 
between Cb and Ba.  Cb antiserum absorbed with Dc variant had antibody to Cb and Fd 838  ANTIGENIC  VARIANTS  O]~ INFLUENZA  A  VIRUS, Ill 
viruses remaining, and the reverse absorption of Dc antiserum with Cb virus left titers to 
PRS-S, As, Ba, and Dc. 
Absorption of Dc antiserum with the fifth variant Fd, left the same antihody spectrum as 
absorption with the third variant Cb, while absorption of Fd antiserum left titers to Fd and 
Cb, similar to absorption of Cb antiserum with Ba or Dc viruses. The cross-relationship be- 
tween alternate variants of this llne suggested by cross-H.I,  and neutralization tests is con- 
firmed by antibody absorption. 
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FIG. 4. Antibody absorption tests with Gf and Hg antisera absorbed with PRS-S, Gf and 
Hg viruses. 
Because of the similarity between Ba and Dc on the one hand and Cb and Fd on the other, 
these pairs of variants were checked by cross-absorption tests, with the results given in Fig. 2. 
Homologous virus removed all antibody in all tests, and is not shown. Since cross-absorption 
with Ba and Dc removed all antibody from both antisera, it can be concluded that these vari- 
ants are very closely related, if not identical. However, absorption of Cb antiserum with Fd 
virus did not remove all antibody, but left titers to PRS-S, and all variants except Fd thereby 
indicating that Fd variant is deficient in some of the antigenic components present in Cb. On 
the other hand, absorption of Fd antiserum with Cb left only a low titer to Fd virus, indicating 
that most of the components present in Fd variant are shared by Cb. 
Absorption of PR8-S antiserum with As variant has been shown to lower the titer of PR8-S 
antiserum (2). However,  absorption of PR8-S antiserum with the other six variants in this DOROTHY  HAMRE~ CLAYTON  G.  LOOSLI~ AND  PAUL  GERBER  839 
series did not alter the antibody titer significantly. This is in agreement with the results ob- 
tained in H.I. and neutralization tests. 
On the basis of the results of these absorption tests, the following antigenic components can 
be listed, named for the viruses in which they are most prominent: (a) PR8-S, (b) Ba-Dc, (c) 
Cb-Fd. 
Cross-H.I. and neutralization tests indicated that Fd and the succeeding variant Gf were 
closely related. By antibody absorption test, however, it was possible to show a slight difference 
between them (Fig. 3). Whereas absorption of both antisera with PR8-S left the same antibody 
spectrum, reacting highest with Cb, Fd, and Gf and lower with De, cross-absorption of these 
antisera with the Fd and Gf variants did not remove all antibody from both sera.  Absorption 
of Fd antiserum with Gf virus left fiters to Cb and Fd variants while absorption of Gf anti- 
serum with Fd virus removed all antibody. Thus, Gf virus apparently lacks components pres- 
ent in Fd but contains no new components that are not shared by Fd virus. 
TABLE IV 
H.I.  Titer Ratios of Antisera of Epidemic Type A  Influenza  Virus Strains  Tested 
with PR8-S, As, Ba, Cb, and De Variant Viruses 
Titer ratios* of ferret antisera~: (yr. isolated) 
Test viruses 
PR8-S 
As22 
Ba25 
Cbl7 
Dc26 
Swine 
1931 
1.5 
<0.5 
<0.5 
<0.5 
<0.5 
PR8 
1934 
100 
17 
3 
2 
3 
Me] 
1935 
25 
6 
<3 
<3 
<3 
Gat  Tal 
1937  1937 
12  25 
6  9 
<2  I  12 
<2  !<1 
<2  1  6 
Alas  Bloom 
1937  1937 
25  25 
I  25  50 
]<3  l<o.s 
F  <0,5  i  <3 
<3  <0.5 
Gid 
1940 
6 
2 
t 
l 
<l 
Dyk  Hems 
1941  1943 
17  25 
1  12  12 
4  1 
<1  <1 
Weiss 
194~ 
16 
12 
2 
<2 
<2 
i 
* Heterologus titer 
X  100. 
Homologous titer 
Antisera prepared from the following group A or A' strains of influenza virus showed no 
H.I. when tested with the above PR8-S and the four variants: WS '33, BH '35, Hickcox '40 
DSP '43, Cam '46, FM1 '47, Sweden '50, Boch '51, Wright '53, and Malaya '54. 
The seventh variant, Hg, has been shown by serological tests to be distinct from previous 
variants, although its broad antibody spectrum indicated that it shared antigens present in 
previous viruses. In Fig. 4, this is brought out by comparing the absorption of Gf and Hganti- 
sera by PR8-S. In Gf antiserum, antibody reacting in varying amounts with Cb, De, Fd, Gf, 
and  ttg viruses remained  after absorption with PR8-S.  In Hg antiserum,  the highest titer 
remaining was to Hg, with lower titers to Fd, Cb, and Gf in that order. Absorption of Gf anti- 
serum by Hg virus removed all the antibody to PR8-S, De, and itself. Absorption of Hg anti- 
serum by Gf left low titers to PR8-S, Cb, Dc viruses, and a high titer to Hg virus. From these 
results it appears that Hg contains considerable amounts of PRS-S antigen as well as a new 
antigen. 
Serological Comparison of Variant Strains with Human Influenza A  and A' Strains.--To 
explore the possibility that the variant strains of PR8-S virus developed in the laboratory 
might antigenically resemble some of the other type A and A ~ strains, cross-H.I, tests were 
carried out with all variants, PR8-S and swine, 14 type A, and 11 type A' influenza strains) 
Since these tests were performed on different days, only titer ratios will be given. Only the 
1 We are indebted to Dr. Keith E. Jensen, CDC Virus and Rickettsia Section, Montgomery, 
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first four variants reacted with some of nine type A antisera; all other variants were negative. 
Titer ratios of antisera of the nine type A influenza strains and four variant viruses are given 
in Table IV. 
TABLE V 
H.I.  Titer Ratios with Variant Antisera and Type A  and A ' Influenza Viruses 
Test viruses  Titer ratios* of antisera 
Name  PRS-S  As  Ba  Cb  Dc  Fd  Gf  Hg  Date 
isolated 
;wine  1931  <  1  <  1 
rype A 
WS  1933  < 1  3 
PR8-S  1934  I00  I00 
Mel  1935  25  25 
BH  1935  1  < 1 
Gatenby  1937  3  6 
Talmey  1937  12  6 
Alaska  1937  25  37 
Bloom  1937  67  33 
Gideon  1940  17  12 
Hickcox  1940  < 1  < 1 
Dyken  1941  50  25 
Hemsbury  1943  25  12 
DSP  1943  < 1  < 1 
Weiss  1943  25  12 
type A' 
Cam  1946  < 1  < 2 
FM  1  1947  < 1  < 2 
Sweden  1950  < 1  < 2 
Boch  1951  <1  <2 
Wright  1953  < i  < 2 
Malaya  1954  < 1  < 2 
Alb/1  1955  <1  <2 
AA/4  1956  <1  <2 
Ned/36  1956  < 1  < 2 
Denver/1  1957  < 1  < 2 
G1/10  1957  < 1  < 2 
<3  <2  <6  <3  <4 
5  25 
75  50 
3  25 
3  4 
<3  2 
19  4 
6  4 
6  25 
2  6 
<3  <2 
6  25 
3  2 
<1  <1 
2  12 
<2  18 
<2  <4 
<2  <4 
<2  4 
<2  18 
<2  <4 
<2  <I 
<2  6 
<2  <1 
<2  <i 
<2  <i 
17  6  12 
50  12  67 
8  5  25 
3  12  6 
<4  5  <4 
9  <3  <4 
<6  8  <4 
25  33  100 
8  4  <12 
<6  <4  <12 
25  12  100 
3  2  25 
<2  <4  <12 
12  4  50 
<2  <2  <2 
<2  <2  <2 
<2  <2  <2 
<2  <2  <2 
<2  <2  <2 
<2  <2  <2 
<2  <2  <4 
<2  <2  <4 
<2  <2  <4 
<2  <2  <4 
<2  <2  <4 
* Heterologous titer 
Homologous titer 
×  100. 
The cross-reactions  shown in Table IV probably can be attributed to the PR8-S component 
in these variants. On the other hand, as seen in Table V, antisera of the variant viruses showed 
H.I. reactions when type A and A' were employed as antigens. It can be noted in Table V that 
WS strain, which was not inhibited by PR8-S antisera, gave titer ratios above 20 with Cb and 
Gf antisera. Among the other type A strains, cross-reactions equal to the cross reaction ob- 
tained with PR8-S antisera were also seen with some of the variants antisera. These reactions, 
however, did not seem to follow any pattern expected of the relative amounts of PRS-S anti- DOROTHY  HAMRE,  CLAYTON  G.  LOOSLI~ AND  PAUL  GERBER  841 
body in variant antisera. For example, Ba antiserum which gave a titer ratio of 75 with PR8-S 
virus hardly inhibited Bloom virus at all, while Fd antiserum, with a titer ratio of 12 with 
PR8-S virus showed a titer ratio of 33 with Bloom virus. However, in the case of Hg anti- 
serum, the high titer ratios obtained with Bloom and Dyken v/ruses probably reflect the large 
amount of PR8-S antibody in this variant antiserum. 
As seen in Table V, only Cb variant antiserum showed inhibition with any of the A' strains. 
Low cross-reactions with this antiserum were noted only with Cam, Wright, and AA/1/55 
viruses. Because this variant appeared unique in this respect, Cb antiserum was tested in 
neutralization tests with Cam and Wright viruses in eggs. However, a titer of less than 16 was 
obtained. On rechecking the H.I. tests with another lot of Cb ferret antiserum, titer ratios of 
12 were obtained with Cam and Wright viruses. No non-specific  inhibitors could be detected 
in any of the RDE-treated antisera by using heated Lee virus. The cross-reaction between 
Cb antiserum and Cam and Wright viruses probably indicates at most a very minor antigenic 
relationship. 
DISCUSSION 
Among the variants  of this  series,  derived  in  sequence from PR8-S virus, 
there was a progressive loss of serological reaction between the variant viruses 
and  PR8-S  antiserum.  Nevertheless  the  antisera  of  the  variants  contained 
antibody reacting to varying degrees with PR8-S virus. One possible explana- 
tion of this apparent paradox could be that the PRS-S antibody produced by 
the variants represents a  common antigen which occupies a minor position in 
the antigenic complex of PRS-S virus,  and that the major antigen of PRS-S 
virus  which  provokes  the  highest  proportion  of antibody present  in  PRS-S 
antiserum  is  not shared by the variants.  This  would account for the failure 
of the variants  to react with  PRS-S antiserum. 
The  variants  described  in  this  series  also  contained  new  antigenic  com- 
ponents. In this context "new" does not mean arising de now in  the variant 
viruses, since no techniques exist at present for delineating all antigenic com- 
ponents present  in influenza viruses.  What are designated  here  as new anti- 
gens  could well  have  been  present  in  quantities  too  small  to  detect  in  the 
parent PRS-S virus.  By absorption of antiserum  of the variant viruses with 
preceding and succeeding viruses  in  the  sequence,  it was possible  to show a 
pattern  of relationship  between  alternate  viruses.  The  present  study would 
seem to leave little  doubt that antigenic variation in influenza A  virus PR8 
can be brought about by passage in mice immunized to PR8 virus, but whether 
the  variants  follow a  predetermined  pattern  or  occur at  random  cannot be 
ascertained without repetition of some of the passages.  Such experiments  are 
now in progress. 
The close relationship between the second variant Ba, and the fourth variant, 
Dc, could indicate a  carry-over of small proportions of Ba virus through the 
passages  leading  to  Cb  variant,  and  then  re-emergence of Ba variant  when 
passages in mice immunized with Cb variant were used for the next series  of 
passages. However, all attempts to detect the presence of Ba variant in mouse 
lung suspensions  containing Cb variant have failed.  This  consisted of inocu- 842  ANTIGENIC  VARIANTS  O~  INFLUENZA  A  VIRUS.  IH 
lation of eggs with a mixture of Cb virus and large amounts of Cb antiserum, 
and  although either  these  eggs yielded no virus,  or  the virus  isolated  was 
identical with Cb, it is possible that the technique  is not sufficiently sensitive 
to detect small proportions  of Ba virus.  Another observation  which does not 
support the hypothesis of carry-over  of Ba virus is the number of passages 
required  in immunized  mice before Dc variant became  established.  By H.I. 
tests,  no significant deviation from Cb variant could be detected before the 
19th passage.  If Ba variant had been present,  it seems likely that less than 
19 passages in an environment unfavorable for growth of Cb variant would 
have sufficed to re-establish Ba. 
Although the fifth and sixth variants,  Fd  and  Gf,  of this line  produced 
significantly  lower  antibody which  reacted  with  PR8-S  virus,  the seventh 
variant, Hg, showed a  significant increase  in the production of PRS-S  anti- 
body. This reappearance  of PR8-S  component in Hg was not unexpected  in 
view of the lower PR8-S  antibody titers of the mice used for this passage. 
Although attributing the  higher  PR8-S  antibody production by Hg to  the 
lowering of PR8-S antibody in the mice used for its passage may not be justi- 
fied, it raised the question  as to what course antigenic variation would follow 
in mice given polyvalent vaccine containing PR8-S virus as a constant factor. 
The production of variants of PR8-S  virus under this condition will be de- 
scribed in the following report (10). 
The  results  of  cross-protection  tests with  this  series of variants and  the 
original PR8-S virus along with comparative antigenicity tests is the subject 
of a  subsequent  report  (11). These studies  further demonstrate the marked 
antigenic  deviation of  the variant viruses  when compared  with the parent 
PRS-S strain. 
None of the variant viruses appeared  identical  with any of 25  type A and 
A'  viruses  tested by cross-H.I,  reactions.  Most  of  the  cross-reactions  were 
obtained with antisera of the variants and the type A and A' viruses. Without 
the use of absorbed  sera it is difficult to interpret these  results.  Presumably 
the variant viruses  do  not share  any major antigens present in any of the 
type A and A' strains employed in these  tests. 
Since Archetti and Horsfall  (12) carried  out their passages  in eggs in the 
presence  of antiserum to  a  related strain rather than in mice  actively im- 
munized with homologous virus, it is difficult to compare the properties  of the 
antigenic  variants  reported  by  them  with  those  described  here.  Recently 
Edney (13) reported the isolation  of three antigenic  variants of Cam virus 
by passage with homologous antiserum in embryonated eggs. The three vari- 
ants were serologically distinguishable,  and two of them were pathogenic for 
mice by the intranasal route although the original Cam strain was not. The 
study reported by Magill  (14) who also carried  out experiments  in actively 
immunized mice is more comparable  to the present one, but use of a different DOROTHY  HAMRE~  CLAYTON  G. LOOSLI, AND  PAUL GERBER  843 
technique  for H.I.  tests  makes  comparison  difficult. Also,  the  methods  for 
evaluating variation are quite different, since the variants described by Magill 
were  tested  with  antisera  of  several  human  strains  rather  than  by  cross- 
reactions with antisera of the variant viruses and their parent strains. 
SUM2~ARY 
Seven variant strains of influenza A  PR8-S  virus, each derived from the 
previous one by serial  passage in the lungs of mice immunized  with the ho- 
mologous agent have been produced.  With the H.L and neutralization pro- 
cedures these variants showed  a progressive serological deviation from the 
parent PR8-S virus.  The seven variants provoked antibodies in varying titers 
to the preceding variants and the parent virus but not in relation to their 
position in the series.  Thus, the scvcnth variant provoked significantly  more 
antibody to the PR8-S virus than did the fifth  variant.  A possible  explanation 
for this  is presented. The first  four variant viruses showed progressively less 
ability to react  with antisera  of the preccding variants and the PR8-S virus, 
and the three most recently dcrived variants showed essentially  no ability  to 
react with PRS-S  and first  variant antisera. The variant viruses remained 
antigcnically stable through numerous  lung passages in normal mice. Cross 
absorption tests revealed common  antigenic components  among  the variant 
viruses and also individual characteristics  which classify  them as being dif- 
ferent from one another. The  implications of these findings in relation to 
studies  by others have been discussed. 
Thc technical  assistance  of  Richard C. Ewert is  gratefully  acknowledged. 
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